AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Asian Watch-and-Wait Database (AWWD)

Recruitingn/aAges 18 Years - anyAllTata Memorial Centre
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The standard treatment approach of localized rectal adenocarcinoma involves neoadjuvant radiotherapy and chemotherapy followed by assessment for surgery and optional adjuvant chemotherapy. However, such patients who achieve complete of near complete clinical response after neoadjuvant therapy are increasingly being managed with the 'Watch-and-Wait strategy' in the recent years. Although safety of such policy has been established, the patient population in the published studies are not represented well by Asian population. Moreover, the data about safety of such policy in the setting of modern neoadjuvant strategies is limited. The Principle Investigator propose a multinational collaborative prospective database study in Asia to systematically collect data on patients being managed with such a strategy. The target population is patients with localized rectal adenocarcinoma achieving near

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Histologically confirmed diagnosis of adenocarcinoma of the rectum * Age โ‰ฅ18 years * Clinical stage T1-T4, N0-N2, M0 at diagnosis * ECOG Performance status 0-1 * Neoadjuvant treatment with either short course or long course radiation therapy and / or chemotherapy * Complete or near complete clinical response after neoadjuvant therapy * Patients willing to be on watch-and-wait strategy. * The distance from anal verge of tumor up to 10 cm (Mid and low rectal tumors) Exclusion Criteria: * Recurrent rectal cancer * Patients with any other concurrent medical or psychiatric condition or disease which would make them inappropriate candidates for entry into this study. * Not willing to consent for the study or to follow up routinely * Patients who cannot read or understand the language of QoL
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Tata Memorial Centre
Mumbai, India
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy